Literature DB >> 563333

Piperoxane reduces the effects of clonidine on aggression in mice and on noradrenaline dependent hypermotility in rats.

J Buus Lassen.   

Abstract

Aggression in isolated male mice and hypermotility in rats produced by the noradrenaline releaser H 77/77 were studied after the s.c. administration of the alpha-adrenergic agonist clonidine and the alpha-antagonist piperoxane. Clonidine 0.005--0.5 mg/kg inhibited both behaviours while piperoxane showed a weak and short-lasting antiaggressive effect and no H 77/77 antagonism. Inactive doses of piperoxane reduced the inhibitory effects of clonidine. The results indicate that isolation-induced aggression in mice and H 77/77-induced hypermotility in rats are behavioural signs related to the availability of noradrenaline at the receptor.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 563333     DOI: 10.1016/0014-2999(78)90372-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  ZK 91296, a partial agonist at benzodiazepine receptors.

Authors:  E N Petersen; L H Jensen; T Honoré; C Braestrup; W Kehr; D N Stephens; H Wachtel; D Seidelman; R Schmiechen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Acute and chronic effects of cocaine on isolation-induced aggression in mice.

Authors:  N A Darmani; M G Hadfield; W H Carter; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  The effect of alpha-adrenoceptor antagonists and metiamide on clonidine-induced locomotor stimulation in the infant rat.

Authors:  Y Nomura; T Segawa
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

4.  Pharmacological characterization of central alpha-adrenoceptors which mediate clonidine-induced locomotor hypoactivity in the developing rat.

Authors:  Y Nomura; K Oki; T Segawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.